The National Agency for Food and Drug Administration and Control (NAFDAC) has dismissed claims circulating on social media that it secretly banned the sale and use of Amoxicillin in Nigeria.
In a statement Monday, Professor Mojisola Adeyeye, Director-General of NAFDAC, clarified that the allegation is false and has no factual basis.
She stressed that the agency publicly notifies Nigerians of any regulatory actions through official channels, including Recalls, Safety Alerts, and Blacklists.
“NAFDAC alerts the public whenever there are substandard or affected products requiring regulatory action
“These safety communications specify the product names, batch numbers, manufacturers, and necessary measures for healthcare providers and patients, ” she said.
The Director-General explained that recent alerts on certain brands and batches of Amoxicillin were product-specific recalls and not a nationwide ban.
For instance, in August 2025, Amoxivue 500mg capsules were recalled for low active pharmaceutical ingredient content.
Other targeted alerts included Astamocil, Astamentin, Annmox, and Jawamox suspensions found to be substandard.
Adeyeye urged the public to disregard misleading videos suggesting a ban and reiterated NAFDAC’s commitment to transparent, science-based regulatory actions to protect public health.
The agency’s proactive safety measures, she added, are designed to ensure that only safe and effective drugs are available to Nigerians while maintaining public confidence in the nation’s healthcare system.
